CoChat
Sign Up
Cited by 132Antimicrobial Resistance in StaphylococcusAntibiotic Use and ResistanceDermatological diseases and infestations

The DOI matches its Crossref record; its reference list is not available.

Epidemiology, Treatment, and Prevention of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections

Open access
Kowalski, Todd J., Berbari, Elie F., Osmon, Douglas R.·2005·Mayo Clinic Proceedings
DOI 10.4065/80.9.1201
Open this paper in CoChat — free accountOpen PDF

Abstract

Since first described In 1961, methicillin-resistant Staphylococcus aureus (MRSA) has become a common nosocomial pathogen. Substantial increases in MRSA infections among nonhospitalized patients are being reported. Methicillin-resistant S. aureus is the most common isolate from skin and soft tissue infections in selected centers in the United States. Community-acquired MRSA strains differ from nosocomial strains in clinically relevant ways, such as in their propensity to cause skin and soft tissue infection and severe necrotizing pneumonia. Clinicians in numerous specialties, particularly primary care physicians, will likely evaluate patients presentIng with community-acquired MRSA and should become familiar with the epidemiology and clinical characteristics of and evolving therapeutic and preventive strategies for this infection.

Overview

Integrity signals

Registry

Crossref · 10.4065/80.9.1201

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 62 · Cited by 132

Research works printed but not linked: 48

  1. Chambers, 2001, The changing epidemiology of Staphylococcus aureus?, Emerg Infect Dis, 7, 178, 10.3201/eid0702.010204 · DOI
  2. National Nosocomial Infections Surveillance System, 2002, National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002, Am J Infect Control, 30, 458, 10.1067/mic.2002.130032 · DOI
  3. Saravolatz, 1982, Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community-acquired outbreak, Ann Intern Med, 96, 11, 10.7326/0003-4819-96-1-11 · DOI
  4. Riley, 1995, Methicillin-resistant Staphylococcus aureus in Western Australia, 1983-1992, J Hosp Infect, 29, 177, 10.1016/0195-6701(95)90327-5 · DOI
  5. Adcock, 1998, Methicillin-resistant Staphylococcus aureus in two child care centers, J Infect Dis, 178, 577, 10.1086/517478 · DOI
  6. Herold, 1998, Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified pre-disposing risk, JAMA, 279, 593, 10.1001/jama.279.8.593 · DOI · Paper page
  7. Centers for Disease Control and Prevention, 1999, Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997-1999, MMWR Morb Mortal Wkly Rep, 48, 707
  8. Salgado, 2003, Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors, Clin Infect Dis, 36, 131, 10.1086/345436 · DOI
  9. Frank, 1999, Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children, Pediatr Infect Dis J, 18, 993, 10.1097/00006454-199911000-00012 · DOI
  10. Katayama, 2000, A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus, Antimicrob Agents Chemother, 44, 1549, 10.1128/AAC.44.6.1549-1555.2000 · DOI
  11. Ma, 2002, Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains, Antimicrob Agents Chemother, 46, 1147, 10.1128/AAC.46.4.1147-1152.2002 · DOI · Paper page
  12. Charlebois, 2004, Origins of community strains of methicillin-resistant Staphylococcus aureus [published correction appears in Clin Infect Dis. 2004;39:291], Clin Infect Dis, 39, 47, 10.1086/421090 · DOI · Paper page
  13. Huletsky, 2004, New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci, J Clin Microbiol, 42, 1875, 10.1128/JCM.42.5.1875-1884.2004 · DOI
  14. Carleton, 2004, Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA, J Infect Dis, 190, 1730, 10.1086/425019 · DOI
  15. Naimi, 2003, Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection, JAMA, 290, 2976, 10.1001/jama.290.22.2976 · DOI · Paper page
  16. Saiman, 2003, Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among post-partum women, Clin Infect Dis, 37, 1313, 10.1086/379022 · DOI · Paper page
  17. Vandenesch, 2003, Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence, Emerg Infect Dis, 9, 978, 10.3201/eid0908.030089 · DOI
  18. Centers for Disease Control and Prevention, 2004, Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders—Hawaii, 2001-2003, MMWR Morb Mortal Wkly Rep, 53, 767
  19. Gauduchon, 2004, Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro, J Infect Dis, 189, 346, 10.1086/380909 · DOI
  20. Liassine, 2004, Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes, J Clin Microbiol, 42, 825, 10.1128/JCM.42.2.825-828.2004 · DOI
  21. Ellis, 2004, Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers, Clin Infect Dis, 39, 971, 10.1086/423965 · DOI
  22. Centers for Disease Control and Prevention, 2003, Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas, 2001-2003, MMWR Morb Mortal Wkly Rep, 52, 992
  23. Centers for Disease Control and Prevention, 2003, Methicillin-resistant staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003, MMWR Morb Mortal Wkly Rep, 52, 793
  24. Wang, 2003, An outbreak of Methicillin-resistant Staphylococcus aureus cutaneous infection in a saturation diving facility, Undersea Hyperb Med, 30, 277
  25. Baggett, 2004, Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska, J Infect Dis, 189, 1565, 10.1086/383247 · DOI
  26. Lin, 2000, Community-acquired methicillin-resistant Staphylococcus aureus endocarditis with septic embolism of popliteal artery: a case report, J Microbiol Immunol Infect, 33, 57
  27. Khan, 2000, Community-acquired methicillin-resistant Staphylococcus aureus brain abscess in an immunocompetent individual, Scand J Infect Dis, 32, 423, 10.1080/003655400750045042 · DOI
  28. Murray, 2004, Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia, Int J Infect Dis, 8, 275, 10.1016/j.ijid.2003.11.008 · DOI
  29. Collins, 2003, Methicillin-resistant Staphylococcus aureus (MRSA) in the practice of otolaryngology—an emerging community acquired organism?, Curr Opin Otolaryngol Head Neck Surg, 11, 179, 10.1097/00020840-200306000-00009 · DOI
  30. Gwynne-Jones, 1999, Community-acquired methicillin-resistant Staphylococcus aureus: a cause of musculoskeletal sepsis in children, J Pediatr Orthop, 19, 413, 10.1097/00004694-199905000-00025 · DOI
  31. Martinez-Aguilar, 2004, Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children, Pediatr Infect Dis J, 23, 701, 10.1097/01.inf.0000133044.79130.2a · DOI
  32. Faden, 2001, Community-acquired methicillin-resistant Staphylococcus aureus and intrafamily spread of pustular disease [letter], Pediatr Infect Dis J, 20, 554, 10.1097/00006454-200105000-00023 · DOI
  33. Centers for Disease Control and Prevention, 2003, Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, 2002-2003, MMWR Morb Mortal Wkly Rep, 52, 88
  34. Yi, 2004, Characterization of community-acquired MRSA associated with staphylococcal scalded skin syndrome [abstract], Abstr Intersci Conf Antimicrob Agents Chemother, 44, 134
  35. Francis, 2005, Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes, Clin Infect Dis, 40, 100, 10.1086/427148 · DOI
  36. Lee, 2004, Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus, Pediatr Infect Dis J, 23, 123, 10.1097/01.inf.0000109288.06912.21 · DOI
  37. Siberry, 2003, Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro, Clin Infect Dis, 37, 1257, 10.1086/377501 · DOI
  38. Stevens, 2000, Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections, Antimicrob Agents Chemother, 44, 3408, 10.1128/AAC.44.12.3408-3413.2000 · DOI
  39. Schrenzel, 2004, A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection, Clin Infect Dis, 39, 1285, 10.1086/424506 · DOI
  40. Nichols, 1999, J Antimicrob Chemother, 44, 263, 10.1093/jac/44.2.263 · DOI
  41. Arbeit, 2004, The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections, Clin Infect Dis, 38, 1673, 10.1086/420818 · DOI
  42. Hepburn, 2004, Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis, Arch Intern Med, 164, 1669, 10.1001/archinte.164.15.1669 · DOI
  43. Gonzalez, 1999, Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms, Clin Infect Dis, 29, 1171, 10.1086/313440 · DOI
  44. Wunderink, 2003, Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia, Chest, 124, 1789, 10.1378/chest.124.5.1789 · DOI
  45. Carpenter, 2004, Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens, Clin Infect Dis, 38, 994, 10.1086/383472 · DOI
  46. Zinderman, 2004, Community-acquired methicillin-resistant Staphylococcus aureus among military recruits, Emerg Infect Dis, 10, 941, 10.3201/eid1005.030604 · DOI
  47. Klempner, 1988, Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy, JAMA, 260, 2682, 10.1001/jama.1988.03410180090035 · DOI
  48. Kresken, 2004, Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001, Int J Antimicrob Agents, 23, 577, 10.1016/j.ijantimicag.2003.11.007 · DOI

Metadata

Authors
Kowalski, T. J., Berbari, E. F., & Osmon, D. R.
Affiliations
Mayo Clinic (US)
Corresponding author
Osmon, Douglas R.
ORCID
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2005-09
Volume
80
Issue
9
Pages
1201-1208
ISSN
0025-6196 (ISSN-L)
DOI
10.4065/80.9.1201
OpenAlex
W1990609233
Cited by
132
References
62
Citations by year
2024: 1 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2015: 2 · 2014: 6 · 2013: 10 · 2012: 6
FWCI
3.25
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Mayo Clinic Proceedings (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
Keywords
methicillin-resistant Staphylococcus aureus, community-acquired MRSA, skin and soft tissue infections, necrotizing pneumonia, MRSA epidemiology, MRSA treatment, MRSA prevention, primary care, nosocomial MRSA
MeSH terms
Humans, Staphylococcal Infections, Methicillin Resistance, Community-Acquired Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review